Journal of Bioequivalence & Bioavailability

5^th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Accepted Abstracts

• Development of validated method for determination of glycyrrhizin content in anti-stress herbal formulations by HPTLC

  Nasir Ali Siddiqui, Perwez Alam, Omer A Basudan and Adnan J AL- Rehaily

  PDF HTML

• Determination of 25-hydroxy vitamin D levels in type-2 diabetic patients by high performance liquid chromatography

  Al Nemer

  PDF HTML

• Indoor air quality interventions with American Indian populations: Community capacity building towards public health intervention development for indigenous communities

  Annie Belcourt

  PDF HTML

• Computational analysis and optimization of therapeutic potentials of phytochemicals isolated from Indian medicinal plants against HIV-1

  Bechan Sharma

  PDF HTML

• Application of emerging pharmaceutical technologies for complex therapeutic challenges for optimal preventive health care

  Lakshmi Putcha

  PDF HTML

• The effect of stomach pH on the bioavailability of weakly basic oncology drugs and formulations options to reduce exposure variability

  Faraj Atassi

  PDF HTML

• Bioavailability and bioequivalence study: Need of hour for patient safety

  R N Gupta

  PDF HTML

• Targeted delivery of diethylcarbamazine citrate to the lymphatics using solid lipid nanoparticles

  Siram Karthik

  PDF HTML

• Mucoadhesive nanoparticles for sustained ocular delivery of bromfenac: In vitro and pharmacokinetic studies

  Bhavani Boddeda and J Vijaya Ratna

  PDF HTML

• Model-based analysis of the relationship between the pharmacokinetics and cerebral perfusion of oxcarbazepine and its metabolite 10-monohydroxy oxcarbazepine in plasma of healthy volunteers

  Natal?cia de Jesus Antunes, Lauro Wichert-Ana, Vera Lucia Lanchote, Sven Van Dijkman, Johan G C Van Hasselt, Eduardo Barbosa Coelho, Veriano Alexandre Junior, Osvaldo Massaiti Takayanagui, Eduardo Tozatto, Maria Paula Marques and Oscar Della Pasqua

  PDF HTML

• Non-compartmental pharmacokinetics modeling of amlodipine in rats

  Bijay Aryal

  PDF HTML

• Chronic traumatic encephalopathy: Is a role for biomarkers premature?

  Rudy J Castellani and George Perry

  PDF HTML

• Regulatory perspectives on bioanalytical inspections for BA/BE studies

  Chase Bourke

  PDF HTML

• Development and validation of liquid chromatography-tandem mass spectrometric method for the quantification of ciprofibrate from human plasma

  Emanual Michael Patelia

  PDF HTML

• Evaluation of in vitro and in vivo aqntitrypanosomal activity of aqueous and methanol leaf extracts of Clutia abyssinica (Euphorbiaceae) and Verbascum sinaiticum (Scrophulariaceae) against trypanosoma congolense field is

  Ermias Mergia

  PDF HTML

• Hydrodynamic investigation of the oligomeric state for kappa carrageenan in solution

  Fahad M Almutairi

  PDF HTML

• Strategic approaches to optimize the power of bioequivalence studies of highly variable drugs through pharmacogenomics

  Francisco E Estevez-Carrizo

  PDF HTML

• A two-way crossover bioequivalence study of cefadroxil after single oral administration of droxil and ultracef suspensions to 24 healthy human volunteers

  F A Mohammed

  PDF HTML

• An LC-MS/MS method for the determination of Cucurbitacin E in rat plasma for pharmacokinetic studies

  Giovana Maria Lanchoti Fiori

  PDF HTML

• Controlled release of doxorubicin from chitosan- poloxamer based pH and temperature sensitive nanogels

  Govind Soni and Khushwant S Yadav

  PDF HTML

• Human: Influence of time between substrate and inducer administration

  Guillaume Baneyx

  PDF HTML

• Pharmacokinetics and pharmacodynamic evaluation of a nanotechnological topical formulation of lidocaine/prilocaine (nanorap) in healthy volunteers

  Gustavo D Mendes

  PDF HTML

• Virtual screening for the discovery of new anticoagulants

  Horacio P?rez-S?nchez

  PDF HTML

• Development of high-capacity, cost-effective, and highly predictive eye-related bioavailability models

  Jasmina Lovrić

  PDF HTML

• Development of oral sustained release dosage form of rizatriptan and its in vitro-in vivo evaluation

  Jeyaprakash M R

  PDF HTML

• In vitro and in vivo assessment of alginate/chitosan nanoparticles for oral delivery of enoxaparin

  Keerti Jain

  PDF HTML

• New inhibitor of the xanthine oxidase regulates cell proliferation

  Danielyan K E

  PDF HTML

• Importance of metabolite data in bioequivalence studies: Sample size and power

  Lara Tutunji and Maha Tutunji

  PDF HTML

• Network medicine: Metabolomics and personalized medicine in neonatal pathologies and in some neurological disease

  Luigi Barberini

  PDF HTML

• Cyclic NGR peptide anchored block co-polymeric nanoparticles as dual targeting drug delivery system for solid tumor therapy

  Madhu Gupta

  PDF HTML

• Harmonizing best practices in bioanalytical methods

  Maha Tutunji

  PDF HTML

• Medicinal plants used as phytotherapy for curing breast cancer: A review of medicinal plants with anti-cancer activity

  M Akram

  PDF HTML

• Applied infrared spectroscopy FTIR for characterization and analytical study of food and pharmaceutical products

  Abdelkhalek Oussama

  PDF HTML

• Comparative analytical and pharmacological profiling of biomarker psoralen in antioxidant active extracts of different species of genus Ficus by validated HPTLC method

  Perwez Alam

  PDF HTML

• Bioavailability of dermal products

  Reinhard H H Neubert

  PDF HTML

• Genomics in bioavailability and bioequivalence

  Wolfgang Sadee

  PDF HTML

• In vitro monitoring of uric acid excretion with different diets in human urine during 24 h by flow injection chemiluminescence

  Jiajia Wang and Zhenghua Song

  PDF HTML